| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918124 | Radiotherapy and Oncology | 2015 | 7 Pages |
Abstract
Higher costs for adjuvant radiation in breast cancer were not associated with a decreased risk of patient-related outcomes suggesting inefficiency in Medicare reimbursements. Future efforts should focus on prospective evaluation of alternative payment models for radiotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Isabel J. Boero, Anthony J. Paravati, Daniel P. Triplett, Lindsay Hwang, Rayna K. Matsuno, Loren K. Mell, James D. Murphy,